RESEARCH ACTIVITIES

All of CZECRIN research activities are aimed at bringing new treatment options closer to patients.

Science and research

CZECRIN is by its nature a research infrastructure focused on clinical research, clinical trials and patient-oriented medicine. The results of research and development are both publishing activities and non-publishing – applied results. All activities are directed towards the support and development of non-commercial clinical trials generating independent evidence-based data leading to the development of new therapies or products, optimization of drug use and individual dosing in standard treatment algorithms, personalized drug development and individual patient treatment; proposals for updating clinical best practices and new diagnostic options

CZECRIN implements scientific and research projects at national and international level.

CPS LIPIDICA
CPS LIPIDICA

CLINICAL PERFORMANCE STUDY LIPIDICA_01-2024 Pancreatic cancer is the 10th most...

read more
CPS LIPIDICA
CT INFURO

CLINICAL TRIAL OF INFURO INFURO is designed as a monocentric, prospective,...

read more
CPS LIPIDICA
CT ETAPA

CLINICAL TRIAL ETAPA ETAPA is a randomized, placebo-controlled trial of early...

read more
CPS LIPIDICA
CT MSC-EB

CLINICAL TRIAL MSC-EB Safety and efficacy of allogeneic adipose-derived...

read more
CPS LIPIDICA
CT HALF

CLINICAL TRIAL HALF Prospective phase II clinical trial evaluating the...

read more
CPS LIPIDICA
CT CoVigi

CLINICAL TRIAL CoVigi CoVigi is a phase IV multicentre post-registration...

read more
CPS LIPIDICA
CT SolidAct

CLINICAL TRIAL SolidAct European DisCoVeRy for Solidarity (EU-SolidAct): a...

read more
CPS LIPIDICA
CT REMED

CLINICAL TRIAL REMEDY Effect of dexamethasone in patients with ARDS and...

read more
CPS LIPIDICA
CT SEOTP

SEOTP - Safety and efficacy of olanzapine therapy in psychosis: influence of...

read more
Clinical trial list
Publishing activities

COOPERATION

CZECRIN collaborates with national and international biomedical infrastructures, research organisations and research consortia, possibly other non-commercial institutions or the WHO. At the same time, in the framework of commercial cooperation, it prefers to work with SMEs with their own biomedical research, in which it participates in the development of regulatory strategies or offers its production capacities in GMP mode. In the framework of European collaborations, CZECRIN is involved in more than 20 research projects funded by FP7 and Horizon 2020. In the context of collaboration with medical infrastructures, it cooperates closely with the biobanks associated with BBMRI and the translational research laboratories within EATRIS, both nationally and internationally within ERIC infrastructures.

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.